Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease. [electronic resource]
- Movement disorders : official journal of the Movement Disorder Society 1990
- 257-9 p. digital
Publication Type: Journal Article
0885-3185
10.1002/mds.870050315 doi
Administration, Oral Aged Aminoquinolines--therapeutic use Dose-Response Relationship, Drug Female Humans Male Middle Aged Parkinson Disease, Secondary--drug therapy Receptors, Dopamine--drug effects